Back to search

United States· US:67172-696_6dbafbc8-4288-4907-83f8-751de6885922

Clear Eyes Maximum Redness Relief

A medicinal product containing naphazoline hydrochloride; glycerin, registered in United States by Prestige Brands Holdings, Inc..

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedClear Eyes Maximum Redness ReliefATC—REGISTER NO.US:67172-696_6dbafbc8…PACKS LISTED4CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
NAPHAZOLINE HYDROCHLORIDE; GLYCERIN
Manufacturer
Prestige Brands Holdings, Inc.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 4

  • ndc11
    67172-696-01
  • ndc11
    67172-696-02
  • ndc11
    6717269601
    1 BOTTLE, DROPPER in 1 CARTON (67172-696-01) / 30 mL in 1 BOTTLE, DROPPER
  • ndc11
    6717269602
    1 BOTTLE, DROPPER in 1 CARTON (67172-696-02) / 15 mL in 1 BOTTLE, DROPPER

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Naphazoline hydrochloride; glycerin in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All naphazoline hydrochloride; glycerin products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f672dd35-efa5-4ca1-b40a-9df05591d2b1
GET /v1/drugs/f672dd35-efa5-4ca1-b40a-9df05591d2b1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "OPHTHALMIC",
  "source": "ndc",
  "strength": ".3; 5",
  "substance": "NAPHAZOLINE HYDROCHLORIDE; GLYCERIN",
  "productndc": "67172-696",
  "dosage_form": "LIQUID",
  "dea_schedule": null,
  "strength_unit": "mg/mL; mg/mL",
  "application_number": "M018",
  "marketing_category": "OTC MONOGRAPH DRUG"
}

See everything about naphazoline hydrochloride; glycerin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.